IP Library Assignment 075780/0968
Patent Assignment
Reel/Frame 075780/0968

Change of Name

Recorded: 2026-05-07 Pages: 5
Assignor
MEI PHARMA, INC.
Executed: 2025-09-02
Assignee
LITE STRATEGY, INC.
9920 PACIFIC HEIGHTS BLVD., SUITE 150, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (9)
Pyrimidinyl and 1,3,5-Triazinyl Benzimidazoles and Their Use in Cancer Therapy
Patent: 8,486,939 →
Application: 12/831,128 →
Publication: US US20110009405A1
(Alpha-Substituted Aralkylamino and Heteroarylalkylamino) Pyrimidinyl and 1,3,5-Triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, and Their Use in Treating Proliferative Diseases
Patent: 9,056,852 →
Application: 13/431,716 →
Publication: US US20120252802A1
(Alpha-Substituted Aralkylamino and Heteroarylalkylamino) Pyrimidinyl and 1,3,5-Triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, and Their Use in Treating Proliferative Diseases
Application: 14/729,700 →
Publication: US US20150265625A1
(Alpha-Substituted Aralkylamino and Heteroarylalkylamino) Pyrimidinyl and 1,3,5-Triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, and Their Use in Treating Proliferative Diseases
Application: 16/040,461 →
Publication: US US20190083506A1
(Alpha-Substituted Aralkylamino and Heteroarylalkylamino) Pyrimidinyl and 1,3,5-Triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, and Their Use in Treating Proliferative Diseases
Application: 16/389,371 →
Publication: US US20200009151A1
(Alpha-Substituted Aralkylamino and Heteroarylalkylamino) Pyrimidinyl and 1,3,5-Triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, and Their Use in Treating Proliferative Diseases
Application: 16/789,954 →
Publication: US US20200316080A1
(Alpha-Substituted Aralkylamino and Heteroarylalkylamino) Pyrimidinyl and 1,3,5-Triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, and Their Use in Treating Proliferative Diseases
Application: 17/845,228 →
Publication: US US20220323449A1
Combination Therapy
Application: 16/613,638 →
Publication: US US20200197403A1
Combination Therapy
Application: 17/684,306 →
Publication: US US20220193086A1
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 16, 2010
From: REWCASTLE, GORDON WILLIAM; GAMAGE, SWARNALATHA AKURATIYA; TSANG, KIT YEE; GIDDENS, ANNA CLAIRE
To: AUCKLAND UNISERVICES LIMITED
Reel/Frame 024842/0743 →
Assignment of Assignor's Interest Sep 16, 2010
From: AUCKLAND UNISERVICES LIMITED
To: PATHWAY THERAPEUTICS LIMITED
Reel/Frame 024996/0891 →
Assignment of Assignor's Interest Nov 16, 2010
From: PATHWAY THERAPEUTICS LIMITED
To: PATHWAY THERAPEUTICS INC.
Reel/Frame 025375/0721 →
Assignment of Assignor's Interest Dec 13, 2012
From: BROWN, S. DAVID; MATTHEWS, DAVID J.
To: PATHWAY THERAPEUTICS INC.
Reel/Frame 029467/0661 →
Assignment of Assignor's Interest Sep 16, 2013
From: PATHWAY THERAPEUTICS, INC.
To: MEI PHARMA, INC.
Reel/Frame 031216/0060 →
Assignment of Assignor's Interest Sep 16, 2013
From: PATHWAY THERAPEUTICS, INC.
To: MEI PHARMA, INC.
Reel/Frame 031215/0779 →
Assignment of Assignor's Interest Oct 3, 2017
From: BROWN, S. DAVID; MATTHEWS, DAVID J.
To: PATHWAY THERAPEUTICS, INC.
Reel/Frame 044114/0177 →
Assignment of Assignor's Interest Oct 3, 2017
From: PATHWAY THERAPEUTICS, INC.
To: MEI PHARMA, INC.
Reel/Frame 044114/0203 →
Assignment of Assignor's Interest Jul 19, 2018
From: PATHWAY THERAPEUTICS, INC.
To: MEI PHARMA, INC.
Reel/Frame 046598/0686 →
Assignment of Assignor's Interest Jul 19, 2018
From: BROWN, S. DAVID; MATTHEWS, DAVID J.
To: PATHWAY THERAPEUTICS, INC.
Reel/Frame 046598/0602 →
Assignment of Assignor's Interest Apr 19, 2019
From: PATHWAY THERAPEUTICS, INC.
To: MEI PHARMA, INC.
Reel/Frame 048953/0017 →
Assignment of Assignor's Interest Apr 19, 2019
From: BROWN, S. DAVID; MATTHEWS, DAVID J.
To: PATHWAY THERAPEUTICS, INC.
Reel/Frame 048950/0941 →
Assignment of Assignor's Interest Nov 26, 2019
From: GOLD, DANIEL P.
To: MEI PHARMA, INC.
Reel/Frame 051124/0511 →
Assignment of Assignor's Interest Feb 14, 2020
From: PATHWAY THERAPEUTICS, INC.
To: MEI PHARMA, INC.
Reel/Frame 051943/0794 →
Assignment of Assignor's Interest Feb 14, 2020
From: BROWN, S. DAVID; MATTHEWS, DAVID J.
To: PATHWAY THERAPEUTICS, INC.
Reel/Frame 052945/0402 →
Assignment of Assignor's Interest Mar 1, 2022
From: GOLD, DANIEL P.
To: MEI PHARMA, INC.
Reel/Frame 059139/0364 →
Assignment of Assignor's Interest Jun 21, 2022
From: PATHWAY THERAPEUTICS, INC.
To: MEI PHARMA, INC.
Reel/Frame 060390/0634 →
Assignment of Assignor's Interest Jun 21, 2022
From: BROWN, S. DAVID; MATTHEWS, DAVID J.
To: PATHWAY THERAPEUTICS, INC.
Reel/Frame 060390/0510 →